N,N-Dimethyl-1-(morpholin-2-yl)methanamine dihydrochloride, 95.0%, 250mg

5-(3-Fluorophenyl)-2-methylpyridine, 95.0%, 5g

Sodium sulphite, min. 98%, pa, ACS, anhydrous, 500 g, plastic packaging.

Dipyrido[3,2-a:2',3'-c]phenazine, 95.0%, 250mg

3,3'-(5'-(3-(Pyridin-3-yl)phenyl)-[1,1':3',1''-terphenyl]-3,3''-diyl)dipyridine, 97%, 1g

3-Chlorobenzophenone, 95.0%, 5g

2-Bromo-5-trifluoroacetylthiophene, 98.0%, 1g

5-Bromonaphthalene-2-carbaldehyde, 98%, 500mg

3-(ethoxycarbonyl)-1-(4-ethylphenyl)-5-methyl-4,5-dihydro-1H-pyrazole-5-carboxylic acid, 95.0%, 2g

tert-Butyl ((2-bromopyridin-4-yl)methyl)carbamate, 95.0%, 1g

4-Methoxyquinoline-2-carboxylic acid, 97.0%, 5g

L-Valine, 3-[[(acetylamino)methyl]thio]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-, 98%, 25g

N-(9-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)-2-phenylacetamide, 97.0%, 5g